PROCEPT BioRobotics (PRCT) Net Margin (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Net Margin data on file, last reported at 38.06% in Q1 2026.

• Net Margin for Q1 2026 came in at 38.06%, down 229.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 31.76% (up 429.0% YoY), and the FY2025 annual result was 31.02%, up 969.0% from the prior year.
• Net Margin grew to 38.06% in Q1 2026 per PRCT's latest filing, from 38.82% in the prior quarter.
• Over five years, Net Margin peaked at 24.73% in Q2 2025 and troughed at 121.05% in Q1 2022.
• A 5-year average of 65.32% and a median of 58.28% in 2024 frame the typical range for Net Margin.
• The sharpest annual moves came in 2022 and 2025: Net Margin jumped 7620 bps in 2022, then tumbled 1173 bps in 2025.
• A 5-year view of Net Margin shows it stood at 104.78% in 2022, then soared by 40 bps to 62.93% in 2023, then jumped by 57 bps to 27.09% in 2024, then tumbled by 43 bps to 38.82% in 2025, then increased by 2 bps to 38.06% in 2026.
• Business Quant data shows PRCT's Net Margin at 38.06% in Q1 2026, 38.82% in Q4 2025, and 25.7% in Q3 2025.